| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 28 | 2019 | 1866 | 2.300 |
Why?
|
| Genetic Diseases, Inborn | 11 | 2025 | 459 | 1.640 |
Why?
|
| Genetic Predisposition to Disease | 23 | 2025 | 3356 | 1.480 |
Why?
|
| Rare Diseases | 8 | 2025 | 208 | 1.480 |
Why?
|
| DNA Copy Number Variations | 13 | 2018 | 1034 | 1.360 |
Why?
|
| Genome, Human | 21 | 2025 | 1331 | 1.350 |
Why?
|
| Homeodomain Proteins | 12 | 2020 | 569 | 1.280 |
Why?
|
| Polymorphism, Single Nucleotide | 37 | 2022 | 2851 | 1.260 |
Why?
|
| Genetic Variation | 16 | 2025 | 1580 | 1.240 |
Why?
|
| Mutation | 36 | 2020 | 6243 | 1.130 |
Why?
|
| Genetic Heterogeneity | 4 | 2025 | 141 | 1.090 |
Why?
|
| Genetic Testing | 14 | 2025 | 1099 | 1.080 |
Why?
|
| Transcription Factors | 20 | 2020 | 2490 | 1.080 |
Why?
|
| Heterotaxy Syndrome | 7 | 2019 | 63 | 1.040 |
Why?
|
| Abnormalities, Multiple | 13 | 2011 | 982 | 0.970 |
Why?
|
| Genome-Wide Association Study | 12 | 2025 | 1830 | 0.960 |
Why?
|
| Models, Genetic | 8 | 2025 | 771 | 0.960 |
Why?
|
| Cardiovascular Abnormalities | 6 | 2014 | 53 | 0.940 |
Why?
|
| Whole Genome Sequencing | 8 | 2025 | 327 | 0.910 |
Why?
|
| Ventricular Outflow Obstruction | 6 | 2011 | 88 | 0.890 |
Why?
|
| Body Patterning | 12 | 2019 | 130 | 0.880 |
Why?
|
| Molecular Sequence Data | 54 | 2016 | 3771 | 0.880 |
Why?
|
| Humans | 236 | 2025 | 132236 | 0.870 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 15 | 2016 | 1045 | 0.840 |
Why?
|
| X Chromosome | 16 | 2002 | 340 | 0.820 |
Why?
|
| Genomics | 12 | 2019 | 1652 | 0.810 |
Why?
|
| Hematopoietic Stem Cells | 19 | 2005 | 551 | 0.770 |
Why?
|
| Vascular Stiffness | 1 | 2023 | 81 | 0.740 |
Why?
|
| Cardiovascular Diseases | 5 | 2024 | 2087 | 0.740 |
Why?
|
| Genetics, Medical | 4 | 2016 | 121 | 0.720 |
Why?
|
| Phenotype | 29 | 2024 | 4538 | 0.720 |
Why?
|
| Heart | 5 | 2017 | 689 | 0.710 |
Why?
|
| Base Sequence | 42 | 2015 | 2900 | 0.700 |
Why?
|
| Coloboma | 4 | 2005 | 41 | 0.690 |
Why?
|
| Aortic Coarctation | 5 | 2013 | 107 | 0.660 |
Why?
|
| Sequence Deletion | 10 | 2017 | 526 | 0.660 |
Why?
|
| Aortic Aneurysm, Thoracic | 5 | 2011 | 705 | 0.660 |
Why?
|
| Exome | 12 | 2025 | 1087 | 0.660 |
Why?
|
| Adenosine Deaminase | 15 | 1995 | 89 | 0.650 |
Why?
|
| Male | 123 | 2024 | 65006 | 0.650 |
Why?
|
| Female | 124 | 2025 | 70778 | 0.650 |
Why?
|
| Zebrafish Proteins | 3 | 2019 | 129 | 0.650 |
Why?
|
| Sequence Analysis, DNA | 14 | 2019 | 1803 | 0.620 |
Why?
|
| Gene Expression Profiling | 8 | 2019 | 1883 | 0.620 |
Why?
|
| Chromosome Mapping | 18 | 2021 | 1096 | 0.600 |
Why?
|
| Genotype | 23 | 2018 | 2702 | 0.600 |
Why?
|
| Retroviridae | 17 | 1994 | 194 | 0.590 |
Why?
|
| Computational Biology | 6 | 2017 | 876 | 0.580 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2013 | 271 | 0.580 |
Why?
|
| Infant | 41 | 2024 | 13048 | 0.570 |
Why?
|
| Parkinson Disease | 1 | 2025 | 738 | 0.560 |
Why?
|
| Choanal Atresia | 4 | 2012 | 18 | 0.560 |
Why?
|
| Polymerase Chain Reaction | 17 | 2005 | 1554 | 0.560 |
Why?
|
| Genetic Linkage | 9 | 2011 | 475 | 0.550 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 156 | 0.550 |
Why?
|
| Genetic Vectors | 22 | 1995 | 927 | 0.540 |
Why?
|
| Critical Illness | 1 | 2022 | 618 | 0.540 |
Why?
|
| Chromosome Deletion | 8 | 2018 | 655 | 0.530 |
Why?
|
| Chromosome Disorders | 3 | 2019 | 311 | 0.520 |
Why?
|
| Pedigree | 25 | 2019 | 1723 | 0.520 |
Why?
|
| Animals | 78 | 2019 | 34842 | 0.500 |
Why?
|
| Amino Acid Sequence | 25 | 2016 | 2669 | 0.500 |
Why?
|
| Multifactorial Inheritance | 3 | 2025 | 167 | 0.480 |
Why?
|
| Aortic Valve Stenosis | 4 | 2009 | 378 | 0.460 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 10 | 2011 | 357 | 0.460 |
Why?
|
| Moyamoya Disease | 1 | 2015 | 42 | 0.460 |
Why?
|
| Transforming Growth Factor beta | 8 | 2009 | 473 | 0.450 |
Why?
|
| Syndrome | 18 | 2018 | 1175 | 0.450 |
Why?
|
| Deafness | 3 | 2005 | 85 | 0.440 |
Why?
|
| Consanguinity | 2 | 2017 | 121 | 0.430 |
Why?
|
| Proteins | 7 | 2016 | 1037 | 0.420 |
Why?
|
| Child, Preschool | 43 | 2024 | 14735 | 0.420 |
Why?
|
| Infant, Newborn | 32 | 2021 | 8548 | 0.420 |
Why?
|
| Genetics, Population | 10 | 2011 | 188 | 0.420 |
Why?
|
| Aorta, Thoracic | 4 | 2023 | 540 | 0.410 |
Why?
|
| Alleles | 15 | 2019 | 1684 | 0.410 |
Why?
|
| Child | 51 | 2025 | 25783 | 0.400 |
Why?
|
| Polymorphism, Genetic | 10 | 2009 | 803 | 0.400 |
Why?
|
| Mice | 55 | 2016 | 18504 | 0.400 |
Why?
|
| Microfilament Proteins | 4 | 2012 | 285 | 0.390 |
Why?
|
| Haplotypes | 10 | 2012 | 544 | 0.390 |
Why?
|
| Bronchiolitis, Viral | 1 | 2013 | 29 | 0.390 |
Why?
|
| Chromosome Aberrations | 6 | 2019 | 590 | 0.390 |
Why?
|
| Breast Neoplasms | 1 | 2025 | 2681 | 0.390 |
Why?
|
| Incidental Findings | 1 | 2013 | 131 | 0.390 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 375 | 0.380 |
Why?
|
| Cohort Studies | 20 | 2020 | 5173 | 0.380 |
Why?
|
| Nucleoside Deaminases | 6 | 1990 | 26 | 0.380 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 196 | 0.370 |
Why?
|
| Genetic Techniques | 2 | 2011 | 104 | 0.370 |
Why?
|
| Fenofibrate | 4 | 2013 | 61 | 0.370 |
Why?
|
| Interferons | 1 | 2013 | 142 | 0.370 |
Why?
|
| Transfection | 12 | 2016 | 996 | 0.370 |
Why?
|
| Family | 6 | 2017 | 595 | 0.370 |
Why?
|
| Gene Expression Regulation, Developmental | 9 | 2012 | 1017 | 0.360 |
Why?
|
| Precision Medicine | 3 | 2016 | 360 | 0.360 |
Why?
|
| Gene Dosage | 4 | 2013 | 449 | 0.360 |
Why?
|
| Aorta | 6 | 2023 | 552 | 0.360 |
Why?
|
| Gene Frequency | 13 | 2011 | 749 | 0.350 |
Why?
|
| Signal Transduction | 12 | 2016 | 4720 | 0.350 |
Why?
|
| Adolescent | 39 | 2024 | 20559 | 0.350 |
Why?
|
| Genetic Diseases, X-Linked | 3 | 2012 | 79 | 0.350 |
Why?
|
| Lymphokines | 5 | 1991 | 66 | 0.340 |
Why?
|
| Nuclear Proteins | 6 | 2016 | 1284 | 0.340 |
Why?
|
| Genetic Markers | 15 | 2013 | 618 | 0.340 |
Why?
|
| DNA Methylation | 5 | 2020 | 1122 | 0.330 |
Why?
|
| Uniparental Disomy | 1 | 2010 | 42 | 0.330 |
Why?
|
| Developmental Disabilities | 8 | 2018 | 749 | 0.330 |
Why?
|
| Cell Adhesion | 2 | 2010 | 320 | 0.320 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2013 | 233 | 0.320 |
Why?
|
| DNA, Complementary | 6 | 2003 | 454 | 0.320 |
Why?
|
| Cell Line | 18 | 2004 | 2724 | 0.320 |
Why?
|
| Craniofacial Abnormalities | 4 | 2009 | 253 | 0.320 |
Why?
|
| Cardiomyopathies | 4 | 2024 | 509 | 0.320 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 71 | 0.310 |
Why?
|
| Likelihood Functions | 2 | 2025 | 120 | 0.310 |
Why?
|
| Membrane Proteins | 9 | 2017 | 1595 | 0.310 |
Why?
|
| DNA Mutational Analysis | 10 | 2010 | 824 | 0.310 |
Why?
|
| Dyslipidemias | 4 | 2013 | 241 | 0.310 |
Why?
|
| ErbB Receptors | 1 | 2011 | 295 | 0.310 |
Why?
|
| Aortic Rupture | 1 | 2010 | 119 | 0.300 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 238 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 2 | 4 | 2013 | 121 | 0.300 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2013 | 377 | 0.300 |
Why?
|
| Immunologic Deficiency Syndromes | 5 | 2016 | 216 | 0.300 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2012 | 231 | 0.300 |
Why?
|
| Cloning, Molecular | 7 | 1998 | 811 | 0.300 |
Why?
|
| Zebrafish | 7 | 2019 | 418 | 0.300 |
Why?
|
| Genome | 3 | 2004 | 504 | 0.290 |
Why?
|
| Hearing Loss | 1 | 2011 | 212 | 0.290 |
Why?
|
| Linkage Disequilibrium | 4 | 2011 | 317 | 0.290 |
Why?
|
| Ehlers-Danlos Syndrome | 3 | 2017 | 52 | 0.290 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2004 | 760 | 0.280 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2014 | 123 | 0.280 |
Why?
|
| Bone Marrow Cells | 9 | 2005 | 258 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 16 | 4 | 2012 | 150 | 0.270 |
Why?
|
| Dosage Compensation, Genetic | 5 | 1995 | 59 | 0.270 |
Why?
|
| Young Adult | 21 | 2020 | 9966 | 0.270 |
Why?
|
| Gene Products, tat | 3 | 1997 | 27 | 0.270 |
Why?
|
| Forkhead Transcription Factors | 5 | 2016 | 387 | 0.270 |
Why?
|
| Genetic Association Studies | 4 | 2020 | 856 | 0.270 |
Why?
|
| Gastrula | 2 | 2011 | 22 | 0.270 |
Why?
|
| DNA Helicases | 2 | 2005 | 240 | 0.270 |
Why?
|
| Adult | 35 | 2024 | 31622 | 0.270 |
Why?
|
| DNA-Binding Proteins | 7 | 2020 | 1980 | 0.270 |
Why?
|
| Heart Ventricles | 6 | 2016 | 785 | 0.260 |
Why?
|
| Comparative Genomic Hybridization | 9 | 2016 | 578 | 0.260 |
Why?
|
| Genomic Imprinting | 3 | 2019 | 130 | 0.260 |
Why?
|
| Growth Inhibitors | 3 | 1991 | 37 | 0.260 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 118 | 0.260 |
Why?
|
| Nodal Protein | 6 | 2009 | 18 | 0.260 |
Why?
|
| Bone and Bones | 2 | 2007 | 301 | 0.260 |
Why?
|
| RNA, Messenger | 9 | 2007 | 2679 | 0.260 |
Why?
|
| Influenza, Human | 4 | 2015 | 700 | 0.260 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2013 | 189 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 22 | 4 | 2012 | 102 | 0.250 |
Why?
|
| Myocardium | 2 | 2012 | 907 | 0.250 |
Why?
|
| Selection, Genetic | 5 | 2007 | 164 | 0.250 |
Why?
|
| Aortic Valve | 3 | 2005 | 485 | 0.250 |
Why?
|
| Mutation, Missense | 7 | 2016 | 937 | 0.250 |
Why?
|
| Agammaglobulinemia | 4 | 2012 | 44 | 0.250 |
Why?
|
| Interleukin-6 | 5 | 1991 | 435 | 0.250 |
Why?
|
| Facial Asymmetry | 1 | 2005 | 18 | 0.240 |
Why?
|
| Cluster Analysis | 7 | 2013 | 430 | 0.240 |
Why?
|
| Gene Rearrangement | 3 | 2013 | 327 | 0.240 |
Why?
|
| Conserved Sequence | 5 | 2015 | 296 | 0.240 |
Why?
|
| Fusion Proteins, bcr-abl | 4 | 2008 | 43 | 0.240 |
Why?
|
| Leukoencephalopathies | 2 | 2018 | 61 | 0.240 |
Why?
|
| Holoprosencephaly | 3 | 2011 | 24 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2019 | 98 | 0.240 |
Why?
|
| Case-Control Studies | 13 | 2019 | 3414 | 0.240 |
Why?
|
| Cell Cycle Proteins | 2 | 2001 | 685 | 0.240 |
Why?
|
| Intellectual Disability | 5 | 2018 | 1094 | 0.240 |
Why?
|
| Obesity | 4 | 2020 | 2399 | 0.230 |
Why?
|
| Germ-Line Mutation | 3 | 2017 | 368 | 0.230 |
Why?
|
| Inheritance Patterns | 3 | 2017 | 131 | 0.230 |
Why?
|
| Genetic Counseling | 3 | 2017 | 246 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2018 | 372 | 0.230 |
Why?
|
| Wolff-Parkinson-White Syndrome | 2 | 2020 | 73 | 0.220 |
Why?
|
| Cells, Cultured | 17 | 2016 | 3046 | 0.220 |
Why?
|
| HeLa Cells | 5 | 2018 | 731 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 2 | 2008 | 1132 | 0.220 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2004 | 64 | 0.220 |
Why?
|
| Semaphorins | 1 | 2004 | 33 | 0.220 |
Why?
|
| Bone Marrow Transplantation | 9 | 1993 | 611 | 0.220 |
Why?
|
| Ear, Middle | 2 | 2016 | 25 | 0.210 |
Why?
|
| Hematopoiesis | 4 | 2008 | 224 | 0.210 |
Why?
|
| Heterozygote | 6 | 2016 | 715 | 0.210 |
Why?
|
| Sequence Homology, Amino Acid | 8 | 2009 | 651 | 0.210 |
Why?
|
| In Situ Hybridization, Fluorescence | 9 | 2010 | 772 | 0.210 |
Why?
|
| Gene Expression | 6 | 2006 | 1563 | 0.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2022 | 946 | 0.210 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 1996 | 128 | 0.210 |
Why?
|
| Stethoscopes | 1 | 2003 | 7 | 0.210 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2020 | 815 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2008 | 294 | 0.200 |
Why?
|
| Elasticity | 1 | 2023 | 78 | 0.200 |
Why?
|
| Gene Deletion | 4 | 2008 | 794 | 0.200 |
Why?
|
| Mitochondrial Diseases | 3 | 2011 | 150 | 0.200 |
Why?
|
| Failure to Thrive | 2 | 2008 | 91 | 0.200 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2018 | 158 | 0.200 |
Why?
|
| Molecular Epidemiology | 1 | 2023 | 146 | 0.190 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2002 | 36 | 0.190 |
Why?
|
| Thymus Gland | 2 | 1994 | 100 | 0.190 |
Why?
|
| Apolipoproteins A | 2 | 2013 | 54 | 0.190 |
Why?
|
| Nephrocalcinosis | 1 | 2002 | 8 | 0.190 |
Why?
|
| Thyroxine | 2 | 2012 | 65 | 0.190 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 2002 | 19 | 0.190 |
Why?
|
| Adenosine Triphosphatases | 3 | 2017 | 198 | 0.190 |
Why?
|
| Sucrose | 1 | 2002 | 37 | 0.190 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 87 | 0.190 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2014 | 90 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 93 | 0.190 |
Why?
|
| Embryonic Development | 2 | 2019 | 215 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 5 | 2013 | 1284 | 0.180 |
Why?
|
| Telemedicine | 2 | 2011 | 506 | 0.180 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2002 | 39 | 0.180 |
Why?
|
| Embryo, Mammalian | 4 | 2012 | 440 | 0.180 |
Why?
|
| Genes | 3 | 1993 | 313 | 0.180 |
Why?
|
| Cell Nucleolus | 1 | 2001 | 50 | 0.180 |
Why?
|
| Immunity, Humoral | 2 | 2013 | 74 | 0.180 |
Why?
|
| Research Design | 2 | 2005 | 743 | 0.180 |
Why?
|
| Malformations of Cortical Development | 2 | 2018 | 54 | 0.180 |
Why?
|
| Homozygote | 4 | 2017 | 548 | 0.180 |
Why?
|
| Gene Duplication | 4 | 2012 | 370 | 0.170 |
Why?
|
| HIV-1 | 2 | 1995 | 484 | 0.170 |
Why?
|
| Carrier Proteins | 3 | 2020 | 1049 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2012 | 742 | 0.170 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2020 | 15 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2009 | 613 | 0.170 |
Why?
|
| Microbiota | 2 | 2016 | 434 | 0.170 |
Why?
|
| Gene Expression Regulation | 9 | 2016 | 2442 | 0.170 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2008 | 102 | 0.170 |
Why?
|
| Oncogene Proteins | 3 | 2008 | 144 | 0.160 |
Why?
|
| Fetal Diseases | 3 | 2019 | 461 | 0.160 |
Why?
|
| Gene Products, rev | 2 | 1997 | 11 | 0.160 |
Why?
|
| Vascular Diseases | 2 | 2017 | 150 | 0.160 |
Why?
|
| Eye Abnormalities | 2 | 2012 | 104 | 0.160 |
Why?
|
| Cranial Irradiation | 1 | 2020 | 72 | 0.160 |
Why?
|
| Sequence Alignment | 7 | 2011 | 615 | 0.160 |
Why?
|
| Calcium | 2 | 2002 | 1080 | 0.160 |
Why?
|
| Severe Acute Malnutrition | 1 | 2019 | 7 | 0.160 |
Why?
|
| Cancer Survivors | 2 | 2020 | 250 | 0.160 |
Why?
|
| Triglycerides | 4 | 2016 | 617 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2006 | 291 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 666 | 0.160 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2014 | 24 | 0.160 |
Why?
|
| Situs Inversus | 2 | 2016 | 26 | 0.150 |
Why?
|
| DNA | 15 | 2011 | 1479 | 0.150 |
Why?
|
| Autopsy | 2 | 2016 | 117 | 0.150 |
Why?
|
| Cardiology | 2 | 2024 | 498 | 0.150 |
Why?
|
| Peroxidases | 1 | 2019 | 29 | 0.150 |
Why?
|
| Pigmentation Disorders | 1 | 2018 | 23 | 0.150 |
Why?
|
| Blotting, Southern | 5 | 2003 | 213 | 0.150 |
Why?
|
| Transduction, Genetic | 5 | 1992 | 294 | 0.150 |
Why?
|
| Genes, Lethal | 3 | 2014 | 77 | 0.150 |
Why?
|
| Siblings | 4 | 2012 | 202 | 0.150 |
Why?
|
| Chromatids | 1 | 1998 | 32 | 0.150 |
Why?
|
| Genetic Carrier Screening | 4 | 2015 | 72 | 0.150 |
Why?
|
| Trisomy | 4 | 2010 | 112 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2008 | 149 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 175 | 0.150 |
Why?
|
| Body Mass Index | 3 | 2020 | 1699 | 0.150 |
Why?
|
| Megalencephaly | 1 | 2018 | 60 | 0.140 |
Why?
|
| Genes, tat | 2 | 1995 | 10 | 0.140 |
Why?
|
| Acute Disease | 1 | 2021 | 1163 | 0.140 |
Why?
|
| Evolution, Molecular | 3 | 2015 | 700 | 0.140 |
Why?
|
| N-Terminal Acetyltransferase A | 1 | 2018 | 10 | 0.140 |
Why?
|
| N-Terminal Acetyltransferase E | 1 | 2018 | 11 | 0.140 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2011 | 66 | 0.140 |
Why?
|
| Lung | 3 | 2016 | 1556 | 0.140 |
Why?
|
| Reproducibility of Results | 5 | 2017 | 3017 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2012 | 152 | 0.140 |
Why?
|
| Mosaicism | 3 | 2018 | 250 | 0.140 |
Why?
|
| DiGeorge Syndrome | 3 | 2008 | 82 | 0.140 |
Why?
|
| Middle Aged | 13 | 2017 | 29032 | 0.140 |
Why?
|
| Brain | 5 | 2015 | 3183 | 0.140 |
Why?
|
| Xenopus | 2 | 2011 | 103 | 0.140 |
Why?
|
| Smad6 Protein | 1 | 2017 | 8 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 2 | 2012 | 234 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 3 | 2020 | 282 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 380 | 0.140 |
Why?
|
| CDC2 Protein Kinase | 1 | 2017 | 36 | 0.140 |
Why?
|
| Bone Marrow | 6 | 2004 | 327 | 0.140 |
Why?
|
| Chromosomes, Human | 4 | 2011 | 130 | 0.140 |
Why?
|
| Marfan Syndrome | 3 | 2012 | 149 | 0.140 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1997 | 261 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2013 | 880 | 0.130 |
Why?
|
| Moloney murine leukemia virus | 3 | 1991 | 18 | 0.130 |
Why?
|
| Antigens, CD | 3 | 1994 | 435 | 0.130 |
Why?
|
| Sex Chromosome Aberrations | 2 | 1999 | 62 | 0.130 |
Why?
|
| Mobius Syndrome | 1 | 2017 | 8 | 0.130 |
Why?
|
| Face | 2 | 2017 | 189 | 0.130 |
Why?
|
| Hemizygote | 1 | 2017 | 13 | 0.130 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 1994 | 16 | 0.130 |
Why?
|
| T-Lymphocytes | 4 | 1996 | 1757 | 0.130 |
Why?
|
| Congenital Abnormalities | 2 | 2014 | 299 | 0.130 |
Why?
|
| Influenza Vaccines | 2 | 2013 | 498 | 0.130 |
Why?
|
| Drinking | 1 | 2017 | 29 | 0.130 |
Why?
|
| Satiety Response | 1 | 2017 | 31 | 0.130 |
Why?
|
| Models, Biological | 4 | 2008 | 1445 | 0.130 |
Why?
|
| Phosphofructokinase-1 | 1 | 2016 | 6 | 0.130 |
Why?
|
| Biomarkers | 5 | 2019 | 3402 | 0.130 |
Why?
|
| Registries | 2 | 2015 | 1591 | 0.130 |
Why?
|
| alpha-Macroglobulins | 1 | 2016 | 6 | 0.130 |
Why?
|
| Quality Control | 2 | 2009 | 123 | 0.130 |
Why?
|
| Tubulin | 1 | 2017 | 73 | 0.130 |
Why?
|
| Acute-Phase Proteins | 2 | 2008 | 45 | 0.130 |
Why?
|
| Genes, Duplicate | 1 | 2016 | 16 | 0.130 |
Why?
|
| Population | 2 | 2009 | 24 | 0.130 |
Why?
|
| Fibrillins | 3 | 2012 | 30 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 9 | 2014 | 4758 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 148 | 0.130 |
Why?
|
| Influenza B virus | 2 | 2015 | 100 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 2008 | 420 | 0.130 |
Why?
|
| Fibrillin-1 | 3 | 2012 | 61 | 0.130 |
Why?
|
| Mexican Americans | 3 | 2009 | 167 | 0.130 |
Why?
|
| Noonan Syndrome | 2 | 2009 | 32 | 0.130 |
Why?
|
| Soybean Oil | 1 | 2016 | 70 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 446 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 33 | 0.120 |
Why?
|
| Death, Sudden | 1 | 2016 | 48 | 0.120 |
Why?
|
| Lymphocytes | 2 | 1995 | 364 | 0.120 |
Why?
|
| DNA Replication | 2 | 2019 | 353 | 0.120 |
Why?
|
| Chromosomes, Human, X | 3 | 2012 | 157 | 0.120 |
Why?
|
| Fish Oils | 1 | 2016 | 80 | 0.120 |
Why?
|
| Otitis Media | 1 | 2016 | 90 | 0.120 |
Why?
|
| Phospholipids | 1 | 2016 | 104 | 0.120 |
Why?
|
| DNA Primers | 6 | 2001 | 636 | 0.120 |
Why?
|
| HIV | 1 | 1997 | 190 | 0.120 |
Why?
|
| Functional Laterality | 1 | 2016 | 192 | 0.120 |
Why?
|
| Apoptosis | 4 | 2008 | 1901 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2016 | 87 | 0.120 |
Why?
|
| Pulmonary Artery | 3 | 2009 | 463 | 0.120 |
Why?
|
| RNA, Untranslated | 1 | 1996 | 112 | 0.120 |
Why?
|
| Spleen | 5 | 2008 | 271 | 0.120 |
Why?
|
| Informed Consent By Minors | 1 | 2015 | 4 | 0.120 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2016 | 67 | 0.120 |
Why?
|
| Genes, rev | 1 | 1995 | 5 | 0.120 |
Why?
|
| Aneuploidy | 2 | 2012 | 143 | 0.120 |
Why?
|
| Atrophy | 1 | 2016 | 251 | 0.120 |
Why?
|
| Genetics | 1 | 2015 | 24 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 394 | 0.110 |
Why?
|
| Biological Therapy | 1 | 2015 | 25 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2011 | 375 | 0.110 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 199 | 0.110 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 494 | 0.110 |
Why?
|
| Genetic Therapy | 6 | 1994 | 720 | 0.110 |
Why?
|
| Algorithms | 6 | 2017 | 1725 | 0.110 |
Why?
|
| Echocardiography | 5 | 2011 | 1126 | 0.110 |
Why?
|
| Abdominal Pain | 1 | 2017 | 314 | 0.110 |
Why?
|
| Language Development Disorders | 2 | 2013 | 179 | 0.110 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2017 | 241 | 0.110 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 167 | 0.110 |
Why?
|
| Scoliosis | 1 | 2016 | 143 | 0.110 |
Why?
|
| Cholesterol, HDL | 2 | 2013 | 398 | 0.110 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 386 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2004 | 570 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1995 | 148 | 0.110 |
Why?
|
| Exons | 7 | 2013 | 806 | 0.110 |
Why?
|
| Hyperoxia | 1 | 2016 | 130 | 0.110 |
Why?
|
| Texas | 6 | 2017 | 3632 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1997 | 503 | 0.110 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1993 | 14 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 466 | 0.110 |
Why?
|
| Dilatation, Pathologic | 2 | 2011 | 89 | 0.100 |
Why?
|
| Antigens, Ly | 1 | 1993 | 35 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2018 | 1234 | 0.100 |
Why?
|
| Receptors, CXCR4 | 2 | 2004 | 71 | 0.100 |
Why?
|
| DNA Breaks | 1 | 2013 | 25 | 0.100 |
Why?
|
| Transcriptome | 3 | 2016 | 1126 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 28 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 31 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 141 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 382 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1304 | 0.100 |
Why?
|
| Nasal Lavage Fluid | 1 | 2013 | 14 | 0.100 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2016 | 211 | 0.100 |
Why?
|
| Autoimmunity | 1 | 2014 | 181 | 0.100 |
Why?
|
| Neuraminidase | 1 | 2013 | 39 | 0.100 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2013 | 123 | 0.100 |
Why?
|
| Angiopoietins | 1 | 2012 | 21 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 451 | 0.100 |
Why?
|
| Gene Flow | 1 | 2012 | 15 | 0.100 |
Why?
|
| Pneumonia | 1 | 2016 | 334 | 0.100 |
Why?
|
| Apolipoproteins | 1 | 2012 | 71 | 0.100 |
Why?
|
| Microcephaly | 3 | 2009 | 354 | 0.100 |
Why?
|
| Marriage | 1 | 2012 | 28 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2015 | 252 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 217 | 0.090 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2013 | 62 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 739 | 0.090 |
Why?
|
| Genetic Pleiotropy | 1 | 2012 | 27 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2012 | 52 | 0.090 |
Why?
|
| Colon | 1 | 2015 | 370 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2015 | 291 | 0.090 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 172 | 0.090 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 90 | 0.090 |
Why?
|
| Antibodies, Viral | 3 | 2013 | 1204 | 0.090 |
Why?
|
| Apolipoproteins B | 1 | 2012 | 140 | 0.090 |
Why?
|
| Alagille Syndrome | 3 | 2008 | 48 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2005 | 94 | 0.090 |
Why?
|
| Mice, Mutant Strains | 3 | 2006 | 377 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2009 | 22 | 0.090 |
Why?
|
| CME-Carbodiimide | 1 | 1991 | 1 | 0.090 |
Why?
|
| Heart Diseases | 2 | 2009 | 513 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 1997 | 770 | 0.090 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 235 | 0.090 |
Why?
|
| Apolipoprotein C-III | 1 | 2012 | 46 | 0.090 |
Why?
|
| Growth Disorders | 2 | 2011 | 191 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 93 | 0.090 |
Why?
|
| Mice, SCID | 6 | 2008 | 604 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 764 | 0.090 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 3 | 1997 | 32 | 0.090 |
Why?
|
| GATA4 Transcription Factor | 1 | 2011 | 38 | 0.090 |
Why?
|
| Feces | 1 | 2015 | 753 | 0.090 |
Why?
|
| Indians, South American | 2 | 2008 | 14 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2011 | 81 | 0.090 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1991 | 6 | 0.090 |
Why?
|
| Genes, erbB | 1 | 2011 | 2 | 0.090 |
Why?
|
| Receptor, ErbB-4 | 1 | 2011 | 9 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2016 | 577 | 0.090 |
Why?
|
| Neuregulin-1 | 1 | 2011 | 13 | 0.090 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2011 | 44 | 0.090 |
Why?
|
| Lipocalins | 2 | 2008 | 35 | 0.090 |
Why?
|
| Rhombencephalon | 1 | 2011 | 48 | 0.090 |
Why?
|
| Ciliary Motility Disorders | 1 | 2010 | 13 | 0.090 |
Why?
|
| Dyneins | 1 | 2010 | 13 | 0.090 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 1423 | 0.090 |
Why?
|
| Retroviridae Infections | 1 | 1990 | 10 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 148 | 0.090 |
Why?
|
| Translocation, Genetic | 3 | 2004 | 357 | 0.090 |
Why?
|
| Ear, Inner | 1 | 2011 | 44 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2010 | 7128 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 926 | 0.080 |
Why?
|
| Hair Cells, Auditory | 1 | 2011 | 65 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2013 | 679 | 0.080 |
Why?
|
| Receptors, Androgen | 2 | 1995 | 410 | 0.080 |
Why?
|
| Chromosome Duplication | 1 | 2011 | 149 | 0.080 |
Why?
|
| Craniosynostoses | 1 | 2012 | 130 | 0.080 |
Why?
|
| Family Practice | 1 | 2011 | 92 | 0.080 |
Why?
|
| Ammonia | 1 | 1990 | 77 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2008 | 311 | 0.080 |
Why?
|
| Kanamycin Kinase | 2 | 2007 | 16 | 0.080 |
Why?
|
| Herpes Simplex | 1 | 1990 | 56 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 2 | 2008 | 333 | 0.080 |
Why?
|
| DNA Repair | 1 | 2013 | 566 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2010 | 155 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2018 | 409 | 0.080 |
Why?
|
| Academic Medical Centers | 2 | 2009 | 333 | 0.080 |
Why?
|
| Cilia | 1 | 2010 | 79 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 797 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2016 | 79 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 701 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2003 | 94 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2011 | 422 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 5 | 1994 | 1050 | 0.080 |
Why?
|
| Bone Density | 1 | 2012 | 370 | 0.080 |
Why?
|
| Hypolipidemic Agents | 1 | 2011 | 189 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 304 | 0.080 |
Why?
|
| Risk Factors | 7 | 2020 | 10948 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2016 | 812 | 0.080 |
Why?
|
| Pediatrics | 1 | 2018 | 1210 | 0.080 |
Why?
|
| Aged | 8 | 2016 | 21471 | 0.080 |
Why?
|
| Andersen Syndrome | 1 | 2009 | 6 | 0.080 |
Why?
|
| Plasmids | 3 | 2005 | 459 | 0.080 |
Why?
|
| RNA, Viral | 1 | 1991 | 565 | 0.070 |
Why?
|
| Microphthalmos | 1 | 2009 | 57 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2020 | 3139 | 0.070 |
Why?
|
| Chromosome Breakage | 2 | 2011 | 159 | 0.070 |
Why?
|
| K562 Cells | 3 | 2008 | 97 | 0.070 |
Why?
|
| Family Health | 2 | 2011 | 256 | 0.070 |
Why?
|
| Protein Binding | 3 | 2018 | 1733 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2511 | 0.070 |
Why?
|
| Amino Acids | 2 | 2013 | 626 | 0.070 |
Why?
|
| alpha-Galactosidase | 3 | 1999 | 20 | 0.070 |
Why?
|
| Zinc Fingers | 2 | 2011 | 122 | 0.070 |
Why?
|
| Electric Countershock | 1 | 2009 | 74 | 0.070 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 60 | 0.070 |
Why?
|
| Mucopolysaccharidosis II | 2 | 1998 | 18 | 0.070 |
Why?
|
| Iduronate Sulfatase | 2 | 1998 | 20 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2013 | 5412 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2008 | 87 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2011 | 215 | 0.070 |
Why?
|
| Prevalence | 3 | 2015 | 2665 | 0.070 |
Why?
|
| Zinc Finger Protein Gli3 | 1 | 2008 | 8 | 0.070 |
Why?
|
| CpG Islands | 2 | 2019 | 343 | 0.070 |
Why?
|
| Genetic Engineering | 2 | 1986 | 164 | 0.070 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2007 | 6 | 0.070 |
Why?
|
| Receptor, Notch1 | 1 | 2008 | 76 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2007 | 7 | 0.070 |
Why?
|
| Leukemia, Experimental | 1 | 2007 | 16 | 0.070 |
Why?
|
| Databases, Genetic | 2 | 2016 | 502 | 0.070 |
Why?
|
| Pilot Projects | 4 | 2017 | 1445 | 0.070 |
Why?
|
| Vaccination | 1 | 2013 | 1018 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2001 | 607 | 0.070 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2014 | 134 | 0.070 |
Why?
|
| Tetralogy of Fallot | 2 | 2000 | 171 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2020 | 6572 | 0.070 |
Why?
|
| Age of Onset | 4 | 2013 | 626 | 0.070 |
Why?
|
| Colony-Forming Units Assay | 3 | 1991 | 69 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1991 | 499 | 0.070 |
Why?
|
| Hyoid Bone | 1 | 2007 | 1 | 0.070 |
Why?
|
| beta-Galactosidase | 2 | 1999 | 139 | 0.070 |
Why?
|
| RNA | 2 | 1992 | 552 | 0.070 |
Why?
|
| Spinal Curvatures | 1 | 2007 | 4 | 0.070 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2007 | 7 | 0.070 |
Why?
|
| Fingers | 1 | 2007 | 66 | 0.070 |
Why?
|
| Leukemia Inhibitory Factor | 3 | 1991 | 27 | 0.070 |
Why?
|
| In Situ Hybridization | 2 | 2011 | 469 | 0.070 |
Why?
|
| Cricoid Cartilage | 1 | 2007 | 16 | 0.070 |
Why?
|
| Segmental Duplications, Genomic | 3 | 2012 | 81 | 0.060 |
Why?
|
| Left-Right Determination Factors | 2 | 2004 | 3 | 0.060 |
Why?
|
| Loss of Heterozygosity | 2 | 2006 | 130 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2008 | 366 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2018 | 3844 | 0.060 |
Why?
|
| Recombinant Proteins | 5 | 1997 | 1350 | 0.060 |
Why?
|
| Cytopathogenic Effect, Viral | 2 | 1997 | 29 | 0.060 |
Why?
|
| Disorders of Sex Development | 1 | 1987 | 71 | 0.060 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 2 | 1997 | 17 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 1444 | 0.060 |
Why?
|
| Microsatellite Repeats | 2 | 2006 | 236 | 0.060 |
Why?
|
| Observer Variation | 2 | 2005 | 305 | 0.060 |
Why?
|
| Animals, Newborn | 3 | 2016 | 1033 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2007 | 380 | 0.060 |
Why?
|
| Defibrillators, Implantable | 1 | 2009 | 204 | 0.060 |
Why?
|
| Endoderm | 1 | 2006 | 23 | 0.060 |
Why?
|
| Luciferases | 3 | 1995 | 129 | 0.060 |
Why?
|
| Triamcinolone Acetonide | 1 | 2006 | 34 | 0.060 |
Why?
|
| Ocular Hypertension | 1 | 2006 | 24 | 0.060 |
Why?
|
| Binding Sites | 2 | 2008 | 1256 | 0.060 |
Why?
|
| Gene Targeting | 1 | 2007 | 173 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 167 | 0.060 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2005 | 9 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2011 | 484 | 0.060 |
Why?
|
| Autistic Disorder | 2 | 2009 | 387 | 0.060 |
Why?
|
| Cell Division | 5 | 2004 | 744 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2005 | 1011 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2014 | 3868 | 0.060 |
Why?
|
| RNA Splice Sites | 1 | 2005 | 99 | 0.060 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2005 | 64 | 0.060 |
Why?
|
| Mice, Inbred C3H | 3 | 2005 | 118 | 0.060 |
Why?
|
| Trinucleotide Repeats | 1 | 2005 | 109 | 0.060 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2005 | 45 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2008 | 213 | 0.060 |
Why?
|
| Molecular Probe Techniques | 1 | 2005 | 23 | 0.060 |
Why?
|
| Prenatal Diagnosis | 3 | 2006 | 631 | 0.060 |
Why?
|
| Pregnancy | 5 | 2019 | 7557 | 0.060 |
Why?
|
| Pneumonia, Viral | 1 | 1990 | 390 | 0.060 |
Why?
|
| Mexico | 1 | 2005 | 186 | 0.060 |
Why?
|
| Hypergammaglobulinemia | 2 | 1996 | 11 | 0.060 |
Why?
|
| Language | 1 | 2006 | 225 | 0.060 |
Why?
|
| Oleanolic Acid | 1 | 2004 | 8 | 0.060 |
Why?
|
| Ligands | 3 | 2009 | 495 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2007 | 232 | 0.060 |
Why?
|
| Maternal Age | 1 | 2005 | 140 | 0.060 |
Why?
|
| Actins | 1 | 2007 | 334 | 0.060 |
Why?
|
| Endoribonucleases | 1 | 2005 | 85 | 0.060 |
Why?
|
| Time Factors | 5 | 2016 | 6456 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2005 | 168 | 0.060 |
Why?
|
| Facies | 3 | 2011 | 156 | 0.060 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2004 | 23 | 0.060 |
Why?
|
| Chromosome Inversion | 1 | 2005 | 78 | 0.060 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2005 | 110 | 0.060 |
Why?
|
| Cell Lineage | 2 | 2012 | 358 | 0.060 |
Why?
|
| Nutritional Status | 1 | 2006 | 294 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 140 | 0.060 |
Why?
|
| Growth Differentiation Factor 1 | 3 | 2009 | 4 | 0.060 |
Why?
|
| Cytochalasin B | 2 | 1981 | 8 | 0.050 |
Why?
|
| Activin Receptors, Type II | 1 | 2004 | 34 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2008 | 569 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2004 | 76 | 0.050 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2004 | 6 | 0.050 |
Why?
|
| Neuromuscular Diseases | 1 | 2004 | 50 | 0.050 |
Why?
|
| Immunoglobulin M | 2 | 1996 | 216 | 0.050 |
Why?
|
| Indians, Central American | 1 | 2003 | 3 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 166 | 0.050 |
Why?
|
| Geography | 3 | 2009 | 123 | 0.050 |
Why?
|
| Heart Murmurs | 1 | 2003 | 13 | 0.050 |
Why?
|
| Pandemics | 1 | 2011 | 1187 | 0.050 |
Why?
|
| Echocardiography, Doppler | 1 | 2004 | 172 | 0.050 |
Why?
|
| Myelin P0 Protein | 1 | 2003 | 29 | 0.050 |
Why?
|
| West Nile Fever | 1 | 2005 | 139 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 305 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2011 | 857 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 540 | 0.050 |
Why?
|
| Introns | 4 | 2016 | 305 | 0.050 |
Why?
|
| Disease Management | 2 | 2017 | 565 | 0.050 |
Why?
|
| Methylation | 2 | 1994 | 208 | 0.050 |
Why?
|
| Demyelinating Diseases | 1 | 2003 | 70 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2006 | 387 | 0.050 |
Why?
|
| Hernia, Umbilical | 1 | 2003 | 43 | 0.050 |
Why?
|
| Pharmacogenetics | 2 | 2015 | 200 | 0.050 |
Why?
|
| Cation Transport Proteins | 1 | 2004 | 100 | 0.050 |
Why?
|
| Mice, Inbred NOD | 4 | 2005 | 316 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 3 | 2008 | 145 | 0.050 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2002 | 12 | 0.050 |
Why?
|
| Reference Standards | 1 | 2003 | 242 | 0.050 |
Why?
|
| DNA Probes | 3 | 2005 | 124 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 1994 | 59 | 0.050 |
Why?
|
| Genes, Dominant | 2 | 2011 | 251 | 0.050 |
Why?
|
| Apolipoprotein A-V | 2 | 2013 | 24 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 143 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 313 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 1671 | 0.050 |
Why?
|
| Length of Stay | 2 | 2018 | 1383 | 0.050 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 162 | 0.050 |
Why?
|
| Risk | 1 | 2004 | 761 | 0.050 |
Why?
|
| Apolipoprotein A-I | 2 | 2013 | 89 | 0.050 |
Why?
|
| Logistic Models | 3 | 2013 | 1842 | 0.050 |
Why?
|
| Arthritis, Juvenile | 1 | 2002 | 42 | 0.050 |
Why?
|
| History, 20th Century | 2 | 2015 | 385 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 125 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 109 | 0.050 |
Why?
|
| Fabry Disease | 2 | 1999 | 18 | 0.050 |
Why?
|
| Interphase | 1 | 2001 | 37 | 0.050 |
Why?
|
| HL-60 Cells | 1 | 2001 | 32 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2002 | 301 | 0.050 |
Why?
|
| Multigene Family | 3 | 1998 | 305 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 198 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2001 | 86 | 0.050 |
Why?
|
| Elastin | 1 | 2001 | 31 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2001 | 161 | 0.050 |
Why?
|
| Models, Economic | 1 | 2021 | 61 | 0.040 |
Why?
|
| Graft Survival | 1 | 2004 | 473 | 0.040 |
Why?
|
| Thymidine Kinase | 2 | 1999 | 90 | 0.040 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2001 | 20 | 0.040 |
Why?
|
| Sex Factors | 1 | 2005 | 1354 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2020 | 17394 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 200 | 0.040 |
Why?
|
| Mitral Valve | 1 | 2003 | 269 | 0.040 |
Why?
|
| Iduronidase | 1 | 2001 | 1 | 0.040 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2001 | 6 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2002 | 617 | 0.040 |
Why?
|
| Europe | 3 | 2006 | 373 | 0.040 |
Why?
|
| Hypertension | 1 | 2010 | 1398 | 0.040 |
Why?
|
| Magnesium | 1 | 1981 | 114 | 0.040 |
Why?
|
| Electrocardiography | 4 | 2011 | 996 | 0.040 |
Why?
|
| Interleukin-3 | 3 | 2005 | 17 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2008 | 895 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 398 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2001 | 1611 | 0.040 |
Why?
|
| Mitosis | 1 | 2001 | 198 | 0.040 |
Why?
|
| Rabbits | 1 | 2001 | 673 | 0.040 |
Why?
|
| Neonatal Screening | 2 | 2012 | 192 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 309 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 305 | 0.040 |
Why?
|
| Neoplasm Transplantation | 3 | 2007 | 384 | 0.040 |
Why?
|
| Fibroblasts | 3 | 2004 | 862 | 0.040 |
Why?
|
| Oncogenes | 1 | 2001 | 177 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 826 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 2 | 1991 | 182 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 64 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2002 | 269 | 0.040 |
Why?
|
| Hemorheology | 1 | 2000 | 25 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2002 | 283 | 0.040 |
Why?
|
| Heart Valve Prosthesis | 1 | 2003 | 331 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 700 | 0.040 |
Why?
|
| Jamaica | 1 | 2019 | 27 | 0.040 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 1999 | 70 | 0.040 |
Why?
|
| Leukopenia | 1 | 2000 | 47 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 543 | 0.040 |
Why?
|
| Gene Library | 2 | 1997 | 213 | 0.040 |
Why?
|
| Nonprescription Drugs | 1 | 2000 | 54 | 0.040 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 49 | 0.040 |
Why?
|
| Zinc | 1 | 2000 | 125 | 0.040 |
Why?
|
| Neural Crest | 1 | 2000 | 54 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2002 | 474 | 0.040 |
Why?
|
| Glaucoma | 2 | 2006 | 79 | 0.040 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 1999 | 2 | 0.040 |
Why?
|
| Multiple Carboxylase Deficiency | 1 | 1999 | 3 | 0.040 |
Why?
|
| India | 2 | 2012 | 238 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2016 | 1120 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 96 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 466 | 0.040 |
Why?
|
| Mice, Inbred CBA | 1 | 1999 | 29 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 207 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2000 | 173 | 0.040 |
Why?
|
| Biotin | 1 | 1999 | 44 | 0.040 |
Why?
|
| Parents | 2 | 2004 | 1080 | 0.040 |
Why?
|
| Williams Syndrome | 1 | 1999 | 41 | 0.040 |
Why?
|
| Metaphase | 1 | 1998 | 33 | 0.040 |
Why?
|
| Anaphase | 1 | 1998 | 13 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2000 | 203 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 576 | 0.040 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1998 | 25 | 0.040 |
Why?
|
| GATA2 Transcription Factor | 1 | 1999 | 46 | 0.040 |
Why?
|
| Blood Vessels | 1 | 1999 | 104 | 0.040 |
Why?
|
| Malawi | 1 | 2019 | 327 | 0.040 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2003 | 462 | 0.040 |
Why?
|
| Centromere | 1 | 1998 | 72 | 0.040 |
Why?
|
| Serrate-Jagged Proteins | 2 | 2008 | 37 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 57 | 0.040 |
Why?
|
| Smad2 Protein | 2 | 2008 | 54 | 0.040 |
Why?
|
| Epigenomics | 1 | 2019 | 191 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 94 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2009 | 158 | 0.040 |
Why?
|
| Fetal Heart | 1 | 2000 | 135 | 0.040 |
Why?
|
| Neutropenia | 1 | 2000 | 205 | 0.040 |
Why?
|
| Jagged-1 Protein | 2 | 2008 | 54 | 0.040 |
Why?
|
| Frameshift Mutation | 2 | 2013 | 201 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 2018 | 59 | 0.040 |
Why?
|
| Liver | 2 | 2016 | 1798 | 0.040 |
Why?
|
| Chromatin | 1 | 2001 | 519 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1998 | 252 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2012 | 1177 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2008 | 2449 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2004 | 802 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1979 | 269 | 0.030 |
Why?
|
| Histones | 1 | 2001 | 535 | 0.030 |
Why?
|
| Infant Care | 1 | 2017 | 47 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 2007 | 441 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2012 | 1656 | 0.030 |
Why?
|
| Kansas | 2 | 2011 | 7 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 436 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2005 | 79 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2019 | 209 | 0.030 |
Why?
|
| Heart Atria | 1 | 2020 | 337 | 0.030 |
Why?
|
| Chromosomes | 1 | 1998 | 139 | 0.030 |
Why?
|
| Biological Evolution | 1 | 1998 | 243 | 0.030 |
Why?
|
| Survivors | 1 | 2019 | 358 | 0.030 |
Why?
|
| Chromosomes, Artificial, Yeast | 2 | 1995 | 42 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 258 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2017 | 26 | 0.030 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2017 | 33 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 2017 | 36 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2017 | 81 | 0.030 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2017 | 33 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 2017 | 32 | 0.030 |
Why?
|
| Lipocalin-2 | 2 | 2008 | 32 | 0.030 |
Why?
|
| Philippines | 1 | 2016 | 23 | 0.030 |
Why?
|
| CD40 Ligand | 2 | 1996 | 64 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 1036 | 0.030 |
Why?
|
| Oryzias | 1 | 2016 | 9 | 0.030 |
Why?
|
| Population Groups | 1 | 2016 | 31 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 28 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 29 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2006 | 1575 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2017 | 105 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 100 | 0.030 |
Why?
|
| Forecasting | 1 | 1998 | 373 | 0.030 |
Why?
|
| Consent Forms | 1 | 2016 | 22 | 0.030 |
Why?
|
| Ocular Motility Disorders | 1 | 2017 | 38 | 0.030 |
Why?
|
| Coroners and Medical Examiners | 1 | 2016 | 15 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 2017 | 56 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 2016 | 29 | 0.030 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2016 | 32 | 0.030 |
Why?
|
| Sex Determination Analysis | 1 | 1996 | 16 | 0.030 |
Why?
|
| Emulsions | 1 | 2016 | 70 | 0.030 |
Why?
|
| Diagnosis | 1 | 2016 | 30 | 0.030 |
Why?
|
| Genomic Library | 2 | 1999 | 40 | 0.030 |
Why?
|
| Y Chromosome | 1 | 1996 | 47 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 1995 | 308 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 134 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 206 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2012 | 796 | 0.030 |
Why?
|
| Anemia | 1 | 2000 | 350 | 0.030 |
Why?
|
| Orbital Diseases | 1 | 2017 | 72 | 0.030 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 22 | 0.030 |
Why?
|
| Cell Movement | 1 | 2000 | 890 | 0.030 |
Why?
|
| Dyspepsia | 1 | 2017 | 108 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2017 | 117 | 0.030 |
Why?
|
| Body Height | 1 | 2017 | 204 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2016 | 54 | 0.030 |
Why?
|
| Recurrence | 3 | 2005 | 1455 | 0.030 |
Why?
|
| Cysteine | 1 | 2016 | 142 | 0.030 |
Why?
|
| Restriction Mapping | 4 | 1999 | 180 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 1995 | 26 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 106 | 0.030 |
Why?
|
| Collagen | 1 | 2017 | 303 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1997 | 356 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2007 | 272 | 0.030 |
Why?
|
| Ethics, Medical | 2 | 2016 | 401 | 0.030 |
Why?
|
| Common Cold | 1 | 2015 | 24 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 260 | 0.030 |
Why?
|
| Chromosome Banding | 2 | 2011 | 140 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 1995 | 14 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 1996 | 686 | 0.030 |
Why?
|
| Disclosure | 1 | 2016 | 153 | 0.030 |
Why?
|
| Rhinovirus | 1 | 2015 | 63 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 223 | 0.030 |
Why?
|
| Hominidae | 1 | 1995 | 25 | 0.030 |
Why?
|
| Age Factors | 2 | 2017 | 2920 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2016 | 247 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2000 | 463 | 0.030 |
Why?
|
| Hospitalization | 2 | 2018 | 1902 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 242 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2016 | 199 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 1829 | 0.030 |
Why?
|
| Cerebellum | 2 | 2016 | 462 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2017 | 149 | 0.030 |
Why?
|
| Reference Values | 2 | 2006 | 703 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2011 | 821 | 0.030 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2014 | 21 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 236 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 364 | 0.030 |
Why?
|
| Densitometry | 1 | 2014 | 18 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 515 | 0.030 |
Why?
|
| Zidovudine | 1 | 1994 | 23 | 0.030 |
Why?
|
| Clone Cells | 1 | 1994 | 179 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2015 | 152 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2015 | 271 | 0.030 |
Why?
|
| Cinnamates | 1 | 1994 | 15 | 0.030 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2017 | 223 | 0.030 |
Why?
|
| Virus Replication | 2 | 1995 | 636 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 46 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2016 | 356 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1995 | 347 | 0.030 |
Why?
|
| CD40 Antigens | 1 | 1993 | 27 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 196 | 0.030 |
Why?
|
| Aqueous Humor | 1 | 1993 | 28 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 302 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1993 | 22 | 0.030 |
Why?
|
| Radiation Protection | 1 | 1993 | 58 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 1994 | 224 | 0.030 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1993 | 4 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 1996 | 240 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 650 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2013 | 123 | 0.030 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 1993 | 2 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 2314 | 0.020 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1992 | 8 | 0.020 |
Why?
|
| Epilepsy | 2 | 2012 | 891 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 3691 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 198 | 0.020 |
Why?
|
| Hybrid Cells | 1 | 1992 | 78 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1992 | 48 | 0.020 |
Why?
|
| Swine | 1 | 2016 | 1179 | 0.020 |
Why?
|
| Granulocytes | 1 | 1993 | 69 | 0.020 |
Why?
|
| Vitrectomy | 1 | 1993 | 91 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2013 | 114 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 364 | 0.020 |
Why?
|
| Angiopoietin-like Proteins | 1 | 2012 | 13 | 0.020 |
Why?
|
| Body Weight | 1 | 2017 | 995 | 0.020 |
Why?
|
| Adenoviridae | 1 | 1995 | 596 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 1994 | 183 | 0.020 |
Why?
|
| Rosuvastatin Calcium | 1 | 2012 | 43 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2012 | 17 | 0.020 |
Why?
|
| Mesoderm | 1 | 2012 | 107 | 0.020 |
Why?
|
| Fluorobenzenes | 1 | 2012 | 39 | 0.020 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 1992 | 11 | 0.020 |
Why?
|
| Blast Crisis | 1 | 1992 | 17 | 0.020 |
Why?
|
| Cricetinae | 1 | 1992 | 381 | 0.020 |
Why?
|
| Mothers | 1 | 2015 | 372 | 0.020 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 1992 | 5 | 0.020 |
Why?
|
| Stromal Cells | 1 | 1994 | 304 | 0.020 |
Why?
|
| Genome, Mitochondrial | 1 | 2012 | 33 | 0.020 |
Why?
|
| Heptanoic Acids | 1 | 2012 | 77 | 0.020 |
Why?
|
| Galactosemias | 1 | 1992 | 14 | 0.020 |
Why?
|
| Simvastatin | 1 | 2012 | 77 | 0.020 |
Why?
|
| Gestational Age | 2 | 2012 | 1227 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2013 | 218 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 687 | 0.020 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 61 | 0.020 |
Why?
|
| United States | 2 | 2018 | 11688 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 153 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 204 | 0.020 |
Why?
|
| Growth Substances | 1 | 1992 | 109 | 0.020 |
Why?
|
| Copper | 2 | 2004 | 75 | 0.020 |
Why?
|
| Carbodiimides | 1 | 1991 | 4 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2140 | 0.020 |
Why?
|
| Butanones | 1 | 1991 | 7 | 0.020 |
Why?
|
| Dystrophin | 1 | 2011 | 41 | 0.020 |
Why?
|
| Sulfuric Acid Esters | 1 | 1991 | 11 | 0.020 |
Why?
|
| Monocytes | 1 | 1993 | 342 | 0.020 |
Why?
|
| Aldehydes | 1 | 1991 | 31 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 588 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1991 | 87 | 0.020 |
Why?
|
| Mutagens | 1 | 1991 | 48 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2012 | 117 | 0.020 |
Why?
|
| Genotyping Techniques | 1 | 2011 | 110 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 468 | 0.020 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2011 | 41 | 0.020 |
Why?
|
| Receptors, Odorant | 1 | 2011 | 39 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 70 | 0.020 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2011 | 11 | 0.020 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1991 | 1 | 0.020 |
Why?
|
| Cell Survival | 1 | 1993 | 868 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2011 | 51 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 263 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1991 | 32 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 82 | 0.020 |
Why?
|
| Apolipoprotein E4 | 1 | 2011 | 47 | 0.020 |
Why?
|
| Culture Media | 1 | 1991 | 182 | 0.020 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2011 | 17 | 0.020 |
Why?
|
| Pyrroles | 1 | 2012 | 182 | 0.020 |
Why?
|
| Videoconferencing | 1 | 2011 | 22 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2011 | 60 | 0.020 |
Why?
|
| Vitreous Body | 2 | 2006 | 96 | 0.020 |
Why?
|
| Rural Health | 1 | 2011 | 44 | 0.020 |
Why?
|
| Helper Viruses | 1 | 1991 | 46 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 600 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 181 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 1285 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1991 | 194 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 136 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1981 | 25 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2012 | 284 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 106 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1991 | 130 | 0.020 |
Why?
|
| Blood Cells | 1 | 1990 | 55 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1990 | 96 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 253 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 1962 | 0.020 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1991 | 106 | 0.020 |
Why?
|
| Contractile Proteins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2011 | 127 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1990 | 39 | 0.020 |
Why?
|
| Seasons | 1 | 2011 | 328 | 0.020 |
Why?
|
| Filamins | 1 | 2010 | 27 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1991 | 492 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2011 | 360 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2003 | 1964 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2011 | 13034 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 651 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 803 | 0.020 |
Why?
|
| Radiography | 2 | 2009 | 819 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 714 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2012 | 418 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 144 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 1989 | 18 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1991 | 1045 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2002 | 4690 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1500 | 0.020 |
Why?
|
| Drug Resistance | 3 | 1995 | 252 | 0.020 |
Why?
|
| Americas | 1 | 2009 | 52 | 0.020 |
Why?
|
| Child Behavior | 1 | 2011 | 236 | 0.020 |
Why?
|
| Phylogeny | 1 | 1991 | 763 | 0.020 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2011 | 309 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 64 | 0.020 |
Why?
|
| Antibodies | 1 | 1990 | 366 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2008 | 58 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 1 | 1988 | 26 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2008 | 29 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1990 | 862 | 0.020 |
Why?
|
| Amidohydrolases | 1 | 1988 | 23 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2009 | 136 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 96 | 0.020 |
Why?
|
| Argentina | 1 | 2008 | 52 | 0.020 |
Why?
|
| Codon | 1 | 2008 | 98 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 1991 | 202 | 0.020 |
Why?
|
| Kinetics | 2 | 1981 | 1130 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2008 | 81 | 0.020 |
Why?
|
| Computer Simulation | 1 | 1991 | 700 | 0.020 |
Why?
|
| Edar Receptor | 1 | 2007 | 9 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2007 | 70 | 0.020 |
Why?
|
| Hirsutism | 1 | 2007 | 24 | 0.020 |
Why?
|
| Antiporters | 1 | 2007 | 35 | 0.020 |
Why?
|
| Aging | 1 | 1995 | 1251 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2008 | 119 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2008 | 107 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 523 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 218 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2007 | 152 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 249 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 1461 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 486 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 246 | 0.020 |
Why?
|
| Middle East | 1 | 2006 | 33 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2007 | 103 | 0.020 |
Why?
|
| Indians, North American | 1 | 2007 | 68 | 0.020 |
Why?
|
| Deficiency Diseases | 1 | 2006 | 9 | 0.020 |
Why?
|
| Markov Chains | 1 | 2007 | 101 | 0.020 |
Why?
|
| Calcinosis | 1 | 1988 | 191 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 236 | 0.020 |
Why?
|
| Liposomes | 1 | 2007 | 203 | 0.020 |
Why?
|
| Defective Viruses | 1 | 1986 | 17 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2008 | 312 | 0.020 |
Why?
|
| Lactase | 1 | 2006 | 41 | 0.020 |
Why?
|
| New York | 1 | 2006 | 72 | 0.020 |
Why?
|
| Jews | 1 | 2006 | 34 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1986 | 40 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 665 | 0.020 |
Why?
|
| Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 1986 | 3 | 0.020 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1986 | 35 | 0.020 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2005 | 5 | 0.020 |
Why?
|
| Limb Deformities, Congenital | 1 | 1987 | 112 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2006 | 188 | 0.020 |
Why?
|
| Injections | 1 | 2006 | 152 | 0.020 |
Why?
|
| Utah | 1 | 2005 | 83 | 0.010 |
Why?
|
| Ataxins | 1 | 2005 | 114 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2005 | 41 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2008 | 332 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1991 | 823 | 0.010 |
Why?
|
| Diet, Protein-Restricted | 1 | 2006 | 82 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 340 | 0.010 |
Why?
|
| Stem Cells | 1 | 1990 | 733 | 0.010 |
Why?
|
| Cataract | 1 | 1987 | 168 | 0.010 |
Why?
|
| Fasting | 1 | 2006 | 302 | 0.010 |
Why?
|
| Tetracycline | 1 | 2005 | 80 | 0.010 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2004 | 3 | 0.010 |
Why?
|
| Molecular Probes | 1 | 2005 | 29 | 0.010 |
Why?
|
| Lentivirus | 1 | 2005 | 83 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 726 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2011 | 721 | 0.010 |
Why?
|
| Flavoproteins | 1 | 2004 | 20 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2008 | 1257 | 0.010 |
Why?
|
| Electron Transport | 1 | 2004 | 57 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2005 | 238 | 0.010 |
Why?
|
| Phosphatidylserines | 1 | 2004 | 49 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 328 | 0.010 |
Why?
|
| Cell Death | 1 | 2005 | 242 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 749 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 3093 | 0.010 |
Why?
|
| PPAR gamma | 1 | 2004 | 89 | 0.010 |
Why?
|
| West Nile virus | 1 | 2005 | 117 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2006 | 232 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 179 | 0.010 |
Why?
|
| Copper-transporting ATPases | 1 | 2004 | 27 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2003 | 69 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2003 | 45 | 0.010 |
Why?
|
| Mitochondrial Myopathies | 1 | 2003 | 28 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2004 | 108 | 0.010 |
Why?
|
| Sural Nerve | 1 | 2003 | 46 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 1990 | 1192 | 0.010 |
Why?
|
| 3T3 Cells | 2 | 1994 | 124 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 303 | 0.010 |
Why?
|
| Systole | 1 | 2003 | 205 | 0.010 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2003 | 115 | 0.010 |
Why?
|
| Karyotyping | 1 | 2003 | 317 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 348 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 339 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 243 | 0.010 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2002 | 2 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 689 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2006 | 293 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 1080 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2006 | 430 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2002 | 36 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 101 | 0.010 |
Why?
|
| Ear | 1 | 2002 | 27 | 0.010 |
Why?
|
| Genitalia | 1 | 2002 | 38 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 438 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 222 | 0.010 |
Why?
|
| Leukemia | 1 | 2005 | 371 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2002 | 179 | 0.010 |
Why?
|
| Software | 1 | 2006 | 731 | 0.010 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 1981 | 4 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2003 | 463 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 2001 | 10 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 3607 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 2001 | 22 | 0.010 |
Why?
|
| Corneal Opacity | 1 | 2001 | 22 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2003 | 536 | 0.010 |
Why?
|
| Tyrosine | 1 | 2001 | 148 | 0.010 |
Why?
|
| Weight Gain | 1 | 2003 | 381 | 0.010 |
Why?
|
| Apnea | 1 | 2001 | 31 | 0.010 |
Why?
|
| Splenomegaly | 1 | 2001 | 32 | 0.010 |
Why?
|
| Growth | 1 | 2001 | 95 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2001 | 82 | 0.010 |
Why?
|
| Self Medication | 1 | 2000 | 21 | 0.010 |
Why?
|
| Serine | 1 | 2001 | 166 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 2000 | 68 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2001 | 87 | 0.010 |
Why?
|
| Acne Vulgaris | 1 | 2000 | 25 | 0.010 |
Why?
|
| Reoperation | 1 | 2003 | 853 | 0.010 |
Why?
|
| Glycerol Kinase | 1 | 1999 | 19 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 547 | 0.010 |
Why?
|
| Glycolipids | 1 | 1999 | 33 | 0.010 |
Why?
|
| Mitomycins | 1 | 1979 | 9 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 749 | 0.010 |
Why?
|
| Colchicine | 1 | 1979 | 39 | 0.010 |
Why?
|
| Vinblastine | 1 | 1979 | 57 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 2165 | 0.010 |
Why?
|
| Gamma Rays | 1 | 1979 | 42 | 0.010 |
Why?
|
| Hydrolases | 1 | 1999 | 61 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1999 | 77 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 2196 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 2230 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 1999 | 635 | 0.010 |
Why?
|
| Deoxyadenine Nucleotides | 1 | 1995 | 6 | 0.010 |
Why?
|
| Cosmids | 1 | 1995 | 42 | 0.010 |
Why?
|
| Cats | 1 | 1995 | 118 | 0.010 |
Why?
|
| Ganciclovir | 1 | 1995 | 101 | 0.010 |
Why?
|
| Monosomy | 1 | 1995 | 25 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1995 | 100 | 0.010 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 1995 | 9 | 0.010 |
Why?
|
| Ephrin-B1 | 1 | 1995 | 9 | 0.010 |
Why?
|
| Polylysine | 1 | 1994 | 11 | 0.010 |
Why?
|
| Capsules | 1 | 1994 | 22 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 1994 | 29 | 0.010 |
Why?
|
| Alginates | 1 | 1994 | 24 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1994 | 41 | 0.010 |
Why?
|
| Purines | 1 | 1995 | 113 | 0.010 |
Why?
|
| Nondisjunction, Genetic | 1 | 1994 | 22 | 0.010 |
Why?
|
| Placenta | 1 | 1999 | 539 | 0.010 |
Why?
|
| Hygromycin B | 1 | 1994 | 2 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1995 | 275 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 1994 | 125 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1995 | 347 | 0.010 |
Why?
|
| Leukocytes | 1 | 1995 | 209 | 0.010 |
Why?
|
| Olivary Nucleus | 1 | 1993 | 11 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1993 | 93 | 0.010 |
Why?
|
| CD18 Antigens | 1 | 1993 | 44 | 0.010 |
Why?
|
| Crossing Over, Genetic | 1 | 1993 | 55 | 0.010 |
Why?
|
| Intraocular Pressure | 1 | 1993 | 128 | 0.010 |
Why?
|
| Pons | 1 | 1993 | 34 | 0.010 |
Why?
|
| Myoclonus | 1 | 1993 | 32 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1993 | 249 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1993 | 114 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1992 | 66 | 0.010 |
Why?
|
| Gentamicins | 1 | 1992 | 87 | 0.010 |
Why?
|
| Drainage | 1 | 1993 | 262 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1993 | 116 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 89 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1993 | 179 | 0.010 |
Why?
|
| Homeostasis | 1 | 1995 | 722 | 0.010 |
Why?
|
| Vaccines | 1 | 1995 | 381 | 0.010 |
Why?
|
| Visual Acuity | 1 | 1993 | 707 | 0.000 |
Why?
|
| Biotinidase | 1 | 1988 | 2 | 0.000 |
Why?
|
| Species Specificity | 1 | 1988 | 542 | 0.000 |
Why?
|